TScan Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TCRX for the last quarter is 566.00 k USD, and it's 92.15% lower compared to the previous quarter. The net income of Q1 24 is -30.14 M USD.